We often hear about the next big thing in stem cell therapy, though few of these promises eventuate or are backed up by evidence.
Well, we think were close to a genuine breakthrough in stem cell therapy, based on new research in Proceedings of the National Academy of Sciences.
We have developed a stem cell technique capable of regenerating any human tissue damaged by injury, disease or aging.The new technique, which reprograms bone and fat cells into induced multipotent stem cells (iMS), has successfully repaired bones and muscles in mice. Human trials are set to begin next year.
Injecting stem cells to repair damaged tissue is not a new concept. Every time someone receives a bone marrow transplant, they have in fact received blood stem cells to rescue their blood production.
But bone marrow is easy to extract and blood is constantly replaced. Therefore, blood stem cells are relatively easy to source.
This is not the case if you need stem cells to repair damage to muscles, cartilage or organs such as the heart and brain. These stem cells are not easy to extract and their turnover is low.
If stem cells are hard to extract, another option is to reprogram mature cells from other parts of the body that are relatively easy to extract. We have developed a method that converts fat or bone cells, which are relatively easy to extract, into induced multipotent stem cells.
This method involves culturing fat or bone cells with a drug called Azacitidine and a naturally occurring growth factor called platelet-derived growth factor. Azacitidine is used to treat blood disorders and has the ability to relax the hard-wired gene expression patterns that make a fat cell a fat cell or a bone cell a bone cell. We think the combination of erasing the cells memory with Azacitidine and forcing the cell to proliferate with the growth factor are key to converting fat and bone cells into induced multipotent stem cells.
UNSW.
The new technique is similar to the limb regeneration of the salamander, which can repair multiple tissue types, depending on which body part needs replacing.
In 2006, Japanese Nobel Prize-winning stem cell researcher Shinya Yamanaka identified a small number of genes that could reprogram skin cells from mice into immature stem cells, which could grow into all types of cells in the body.
However, these induced pluripotent stem (iPS) cells, like embryonic stem cells, which are derived from early embryos, are not suitable as a stem cell therapy because they can form tumours rather than repairing damaged tissue.
Since then, scientists have identified different combinations of genes that can reprogram skin or other cells into tissue-specific stem cells that only make cells of a single type of tissue.
A drawback with these reprogramming methods is the use of viral elements to force gene expression. Researchers use a virus as a mechanism to inject the gene into the cell.
Multipotent stem cells, in contrast, are produced without using any viral elements. They can regenerate damaged tissues without making unwanted tissues or tumors at the site of transplantation.
We have reprogrammed mouse bone cells into induced multipotent stem cells and injected these cells into mice with damaged bone and muscle.
We were astounded by the ability of these induced multipotent stem cells to regenerate these damaged tissues and also generate their own blood supply to carry nutrients to these developing tissues.
The transplanted cells appear to follow instructions from adjacent cells and divide and mature in an orderly fashion.
We are still investigating the safety and regenerative potential of human-induced multipotent stem cells.
We have injected human-induced multipotent stem cells, made by reprogramming human fat cells, into our animal models of tissue injury. We are monitoring signals from these cells and know they are retained at the site of injection.
In a few months, we will retrieve tissues from these mice to measure the contribution from transplanted human-induced multipotent stem cells to tissue regeneration in mice.
We need evidence of robust tissue regeneration and the absence of any unwanted tissues or tumours at these sites before commencing human trials.
The process of human induced multipotent stem cell production is free of animal products and is being developed to meet manufacturing standards appropriate for human cell transplantation.
Our initial clinical focus will be using induced multipotent stem cells either as a stand-alone treatment or with spinal implants to treat degenerative disc disease towards the end of 2017.
Low back and neck pain is frequently associated with degenerative disc disease and is a major cause of disability, affecting millions of people globally with crippling physical and economic costs.
Our aim is to use induced multipotent stem cells to regenerate discs to retain the flexibility of the native spine or to stabilise spinal implants by helping them fuse with adjacent bone.
We need further research to understand how mouse- and human-induced multipotent stem cells respond to signals from damaged tissues. It will also be important know how long induced multipotent stem cells remain at sites of transplantation and retain their ability to proliferate and make new tissues.
Nevertheless, this efficient virus-free method of generating tissue regenerative stem cells brings us a step closer to realising stem cell therapy for repairing tissue injury in the human body.
By John Pimanda, Associate Professor of Medicine and Stem Cell Biology, UNSW Australia; Ralph Mobbs, Neurosurgeon at the Prince of Wales Hospital; Conjoint Lecturer, UNSW Australia, and Vashe Chandrakanthan, Researcher, regenerative medicine, UNSW Australia. This article was originally published on The Conversation. Read the original article.
See the original post:
Regenerating Body Parts: Fat Cells to Stem Cells to Repair ...
- BioRestorative Therapies IFATS 2024 Presentation to - GlobeNewswire - September 21st, 2024
- Fasting may help improve immune system; 3 reasons why one should fast at least once a week or a month - Times Now - February 24th, 2023
- Alpilean Weight Loss Reviews (Legit Or Fake) Dont Try Alpine Ice Hack Diet Before You See This! - Outlook India - February 24th, 2023
- Stevens Institute of Technology Professors Use Interdisciplinary Collaboration to Enhance the Field of 3D-Printed Tissues - India Education Diary - February 24th, 2023
- Stress can throw off circadian rhythms and lead to weight gain - Medical News Today - August 19th, 2022
- Scientists Aim to Bring the Tasmanian Tiger Back From Extinction Mother Jones - Mother Jones - August 19th, 2022
- Benefits Of Ozone Therapy In Pain Medicine - Nation World News - August 19th, 2022
- New Discovered Adipokines Associated with the Pathogenesis of Obesity | DMSO - Dove Medical Press - August 11th, 2022
- Slimvance Reviews - Does This Fat Burner Really Work? - Outlook India - August 11th, 2022
- Mesenchymal stem cells - PubMed - June 16th, 2022
- Stem cells: Sources, types, and uses - Medical News Today - June 16th, 2022
- Fat Cells - The Definitive Guide | Biology Dictionary - June 16th, 2022
- Stem Cells For Back Pain | Stem Cells For Herniated Discs - June 16th, 2022
- 2022-06-13 | OTCPK:BRTXD | Press Release | BioRestorative Therapies - Stockhouse - June 16th, 2022
- Hepatic Diseases and Associated Glucose Intolerance | DMSO - Dove Medical Press - June 16th, 2022
- Why Fitness Experts Are Obsessed With "Bulletproofing" the Body - InsideHook - June 16th, 2022
- New Stem cell conveying hydrogel could assist the heart with recuperating myocardial ischemia - Microbioz India - August 17th, 2021
- Participants Diagnosis Halts Gene Therapy Clinical Trial - The Scientist - August 17th, 2021
- The Involuted Palate, or the Savage Crinkle of Future Snacks - lareviewofbooks - August 17th, 2021
- Time to Go Sushi With Cellular Salmon; When Pet Owners Tire of Their Minions - The SandPaper - August 17th, 2021
- Adipose-derived Stem Cell Market Analysis, Key Company Profiles, Types, Applications and Forecast To 2027 The Courier - The Courier - May 27th, 2021
- Global Cell Therapy Markets, Technologies, and Competitive Landscape Report 2020-2030: Applications, Cardiovascular Disorders, Cancer, Neurological... - May 27th, 2021
- What is lab grown meat? A scientist explains the taste, production and safety of artificial foods - BBC Focus Magazine - May 27th, 2021
- Rheumatoid Arthritis Stem Cell Therapy Market share, growth drivers, demand, supply, challenges, and investment opportunities by 2028 - WhaTech - May 27th, 2021
- Obesity-Related Inflammation and Endothelial Dysfunction in COVID-19: | JIR - Dove Medical Press - May 27th, 2021
- The hunt for the master cow that will feed the world - Wired.co.uk - May 27th, 2021
- Australia's Magic Valley On How to Turn Cells From "Cell Volunteer" Lucy the Lamb Into Lamb Steaks and Chops - vegconomist - the vegan... - May 27th, 2021
- Clearing Cellular Dead Wood | In the Pipeline - Science Magazine - May 27th, 2021
- University of Pittsburgh Won't Explain its Planned Parenthood Ties | Opinion - Newsweek - May 27th, 2021
- Smart Stem Cells Made From Fat Have the Power to Heal - Freethink - February 14th, 2021
- Network-based screen in iPSC-derived cells reveals therapeutic candidate for heart valve disease - Science - February 14th, 2021
- Their Goal: Meat That's Better Than Meat | Tufts Now - Tufts Now - January 31st, 2021
- Gut microbiota: How does it interact with the brain? - Medical News Today - December 30th, 2020
- The 10 Best Herbs for Liver Health: Benefits and Precautions - Healthline - December 19th, 2020
- Startups are racing to reproduce breast milk in the lab - MIT Technology Review - December 19th, 2020
- The facts about the danger of melanoma - The Hudson Reporter - December 19th, 2020
- And Now, a Moment for Culture(d Meat) - The Spoon - December 4th, 2020
- How to live longer: Calorie restriction may reset your biological body clock - Express - December 4th, 2020
- Future Meat is cutting costs on mass production with an unlikely cellular approach - The Spoon - November 30th, 2020
- BioRestorative Therapies Emerges from Chapter 11 Reorganization - OrthoSpineNews - November 25th, 2020
- The Adipose Tissue Derived Stem Cells market to grow in the wake of incorporation of the latest technology - The Think Curiouser - November 7th, 2020
- Global Cell Therapy Technologies, Competitive Landscape & Markets, 2019-2020 & Forecast to 2029 - ResearchAndMarkets.com - Yahoo Finance - November 7th, 2020
- Blocking energy pathway reduces GVHD while retaining anti-cancer effects of T-cells - Science Codex - November 7th, 2020
- Singapore startup Shiok Meats re-creates shrimp in the lab - Los Angeles Times - October 10th, 2020
- Aqua-Spark Announces an Investment in Singapore-based Shiok Meats, the First Cell-Based Company to Produce Clean, Sustainable, Cruelty-Free Shrimp and... - October 6th, 2020
- Orgenesis to acquire regenerative medicine company Koligo Therapeutics - Pharmaceutical Business Review - September 30th, 2020
- Heart attack patches may save lives in US and beyond - Galveston County Daily News - September 30th, 2020
- Orgenesis Announces Agreement to Acquire Koligo Therapeutics, a Leader in Personalized Cell Therapies - GlobeNewswire - September 30th, 2020
- Bariatric surgery is booming, as obese patients worry about their Covid-19 risks - The Daily Briefing - September 30th, 2020
- Global Stem Cell Reconstructive Market- Industry Analysis and Forecast (2020-2027) - Unica News - September 30th, 2020
- Regenerative medicine and war: The next breakthrough in treating injured veterans? - Genetic Literacy Project - September 29th, 2020
- Sherrie Hewson celebrates 70th birthday with second face lift to transform her looks - The Sun - September 15th, 2020
- Two Austin Women Hope to Build the First Lab-Grown Brisket - Texas Monthly - September 15th, 2020
- FDA Clears Jointechlabs' MiniTC for Point-of-Care Fat Tissue Processing and its Broad Range of Applications - PRNewswire - August 26th, 2020
- Photos That Reveal the Hidden Side of Things - Obsev - August 26th, 2020
- Research Roundup: Lasting Immunity to COVID-19 and More - BioSpace - August 25th, 2020
- The Truth About Cosmetic Treatments review a format in need of a facelift - The Guardian - August 25th, 2020
- Survivors of Pediatric Cancers May Experience Lasting Impact on Heart, Metabolic Health Following Radiation Therapy - Pharmacy Times - August 15th, 2020
- AgeX Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business Update - Business Wire - August 15th, 2020
- Global Stem Cell Reconstructive Market- Industry Analysis and Forecast (2020-2027) - Good Night, Good Hockey - August 15th, 2020
- Meet The 12 Next-Gen Food Techs Transforming The Future Of Protein - Green Queen Media - August 15th, 2020
- Meat-lover who wants to save the planet? 3D printed steaks are your solution - ThePrint - July 12th, 2020
- Fat stem cells improve prognosis in patients with Covid-19 ... - July 11th, 2020
- Making Sense of Stem Cells and Fat Grafting in Plastic ... - July 11th, 2020
- Tip Sheet: SARS-CoV-2 antibodies, COVID-19 and health disparities, eating in tough times and immune protection in breast milk - Fred Hutch News... - July 9th, 2020
- Blood factors transfer beneficial effects of exercise on neurogenesis and cognition to the aged brain - Science Magazine - July 9th, 2020
- Fasting is not starvation or a fad, it is a discipline: Luke Coutinho - The Indian Express - July 9th, 2020
- Is Meat Grown in a Lab Really Meat? - The New York Times - July 7th, 2020
- What if mammoths are brought back from extinction? - The Economist - July 7th, 2020
- Cancer Stem Cells (CSCs) Market Recent Industry Developments and Growth Strategies Adopted by Players - Cole of Duty - July 1st, 2020
- Coronavirus symptoms: How COVID-19 can damage the brain - what to look for - Express - July 1st, 2020
- Westerleigh resident is alive because of stem cell therapy by his doctor -- for free. Heres his story. - SILive.com - June 13th, 2020
- Regenerative Therapy Options for Horses With Osteoarthritis - TheHorse.com - June 13th, 2020
- Fat cells remember their diets early in life - Massive Science - June 13th, 2020
- Patient uses fat stem cells to repair his wrist - CNN - June 10th, 2020
- FDA Warns About Stem Cell Therapies | FDA - June 10th, 2020
- Regenerative Therapies: Helping Horses Self-Heal The Horse - TheHorse.com - May 31st, 2020
- AgeX Therapeutics and Sernova to Collaborate to Engineer Universal Locally Immune Protected Cell Therapies for Type I Diabetes and Hemophilia A -... - May 31st, 2020
- Hair regeneration using stem cells to treat baldness - BioNews - May 27th, 2020
- AgeX Therapeutics, Inc. Appoints Andrea Park as Chief Financial Officer - Yahoo Finance - May 27th, 2020